Clinical studies De Cordi D et al.
Gelclair®: potentially an efficacious treatment for chemotherapy-induced mucositis
  • The study demonstrated the efficacy of Gelclair® in patients undergoing different chemotherapy treatments. 

Graf improvement.jpg



  • More than the 80% of patients reported a benefit in pain management and in functionality.
  •  In 57% of patients the grade of mucositis decreased after 3 days of Gelclair® application.


De Cordi D et al, Presented at the Italian Anti Tumor League III Congress of Professional Oncology Nurses Conegliano, October 10-12, 2001.

HELSINN This website is for Ex U.S. residents only Last Update: 19.02.2018
Sitemap Privacy and Cookies Policy Terms of Use